Intellectual Property,
Civil Litigation
Mar. 20, 2018
Biotech company sues one rival, seeks injunction against another
Biotechnology company Illumina Inc. has sued Natera Inc. for patent infringement over its use of a noninvasive prenatal test.
Biotechnology company Illumina Inc. sued Natera Inc. for patent infringement over its use of a noninvasive prenatal test.
The suit follows Illumina's $27 million win against Ariosa Diagnostics Inc. in January for infringement claims on other patents for prenatal tests. On Friday, Illumina also filed a motion for permanent injunction in that case -- the same day as the new complaint against Natera.
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In